Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 6 | 6 |
| List of Tables | 9 | 2 |
| List of Figures | 11 | 1 |
| Introduction | 12 | 1 |
| Global Diabetes Care Devices Market - Overview | 13 | 1 |
| Disease Overview | 13 | 1 |
| Types of Diabetes | 13 | 1 |
| Prevalence | 13 | 1 |
| Diabetes Care Devices | 13 | 1 |
| Global Diabetes Care Devices Market - Market Characterization | 14 | 10 |
| Diabetes Care Devices Market, Global, Revenue ($bn), 2004-2011 | 14 | 1 |
| Diabetes Care Devices Market, Global, Revenue ($bn), 2011-2018 | 15 | 1 |
| Diabetes Care Devices Market, Global, Key Company Share (%), 2011 | 16 | 1 |
| Global Diabetes Care Devices Market: Key Trends | 17 | 1 |
| Increase in Healthcare Spending Attributable to Diabetes | 17 | 1 |
| Increase in Awareness to Help Control Diabetes and Manage Complications | 18 | 1 |
| Global Diabetes Care Devices Market: Market Dynamics | 19 | 1 |
| Market Drivers | 19 | 1 |
| Increase in the Prevalence of Diabetes is Leading to Significant Demand for Diabetes Care Devices | 19 | 1 |
| Introduction of New Generation, Technologically Advanced Devices will Boost the Demand for Diabetes Care Devices | 20 | 1 |
| Closed Loop Insulin Delivery Systems that Aim to Achieve Tight Glycemic Control May Revolutionize the Management of Diabetes in Insulin-Dependent Patients | 21 | 1 |
| Increase in the Usage of Diabetes Homecare Devices to Drive Market Growth | 21 | 1 |
| Market Restraints | 22 | 1 |
| Lack of Sufficient Diagnosis and Treatment of Diabetes, Especially in Developing Countries, Hinders Market Growth | 22 | 1 |
| Warning Letters from Regulatory Agencies Related to Product Issues Raise Concerns Amongst Consumers and Affect Adoption Rates | 22 | 1 |
| Increased Risk of Infection due to the Invasive Nature of Devices Raises Patient Concerns and Affects Market Growth | 23 | 1 |
| Product Recalls Affect Physician and Patient Perceptions, Decrease Adoption Rates and Restrain Market Growth | 23 | 1 |
| Global Diabetes Care Devices Market - Category Analysis | 24 | 14 |
| Glucose Monitoring Devices Market, Global, Revenue ($m), 2004-2011 | 24 | 1 |
| Glucose Monitoring Devices Market, Global, Revenue ($m), 2011-2018 | 25 | 2 |
| Glucose Monitoring Devices Market, Global, Key Company Share (%), 2011 | 27 | 1 |
| Glucose Monitoring Devices Market: Market Dynamics | 28 | 1 |
| Market Drivers | 28 | 1 |
| New Product Launches to Encourage Greater Adoption and Drive Market Growth | 28 | 1 |
| Innovative and Non-Invasive Technologies to Drive Growth of the Glucose Monitoring Devices Market | 29 | 1 |
| Technologically Advanced Blood Glucose Meters will Boost Growth of the Market | 29 | 1 |
| Patient Convenience Offered by the Continuous Glucose Monitoring and Insulin Pump Combination System is Expected to Drive Growth of the Market | 29 | 1 |
| Support from Big Firms to Expand Knowledge of Diabetes in Developing Countries Presents Vast Potential for Market Growth | 30 | 1 |
| Market Restraints | 31 | 1 |
| Discontinued Products and Device Recalls Affect Market Shares and Lead to a Decline in Market Growth | 31 | 1 |
| Cost to be the Major Deterrent for the Uptake of Continuous Glucose Monitoring Systems | 31 | 1 |
| Lack of Reimbursement for Glucose Monitoring Devices in Emerging Countries Hinders Growth of the Market | 31 | 1 |
| Insulin Delivery Devices Market, Global, Revenue ($m), 2004-2011 | 32 | 1 |
| Insulin Delivery Devices Market, Global, Revenue ($m), 2011-2018 | 33 | 1 |
| Insulin Delivery Devices Market, Global, Key Company Share (%), 2011 | 34 | 1 |
| Insulin Devices Market: Market Dynamics | 35 | 1 |
| Market Drivers | 35 | 1 |
| Conversion of Multiple Dose Injector Users to Insulin Pumps to be a Major Driver for the Insulin Pump Market | 35 | 1 |
| Demand for Technologically Advanced Insulin Delivery Devices to Increase in the Future | 35 | 1 |
| Market Restraints | 36 | 1 |
| Product Related Issues Call for Market Withdrawals and Restrain Market Growth | 36 | 1 |
| Negative Publicity for Insulin Pumps Due to Software Issues May Lead to Decreased Levels of Adoption and Affect Market Value | 36 | 1 |
| High Cost of Insulin Pumps and Lack of Awareness in India and China Hinder Growth of the Market | 36 | 1 |
| Complications Associated with Insulin Pump Malfunction Affect Adoption Rates | 37 | 1 |
| Global Diabetes Care Devices Market - Country Analysis | 38 | 25 |
| Global Diabetes Care Devices Market: Cross Country Analysis | 38 | 1 |
| Historic and Forecast Revenue, By Country | 39 | 1 |
| Diabetes Care Devices Market, the US, Revenue ($m), 2004-2011 | 39 | 1 |
| Diabetes Care Devices Market, the US, Revenue ($m), 2011-2018 | 40 | 1 |
| Diabetes Care Devices Market, Canada, Revenue ($m), 2004-2011 | 41 | 1 |
| Diabetes Care Devices Market, Canada, Revenue ($m), 2011-2018 | 42 | 1 |
| Diabetes Care Devices Market, Germany, Revenue ($m), 2004-2011 | 43 | 1 |
| Diabetes Care Devices Market, Germany, Revenue ($m), 2011-2018 | 44 | 1 |
| Diabetes Care Devices Market, France, Revenue ($m), 2004-2011 | 45 | 1 |
| Diabetes Care Devices Market, France, Revenue ($m), 2011-2018 | 46 | 1 |
| Diabetes Care Devices Market, the UK, Revenue ($m), 2004-2011 | 47 | 1 |
| Diabetes Care Devices Market, the UK, Revenue ($m), 2011-2018 | 48 | 1 |
| Diabetes Care Devices Market, Italy, Revenue ($m), 2004-2011 | 49 | 1 |
| Diabetes Care Devices Market, Italy, Revenue ($m), 2011-2018 | 50 | 1 |
| Diabetes Care Devices Market, Spain, Revenue ($m), 2004-2011 | 51 | 1 |
| Diabetes Care Devices Market, Spain, Revenue ($m), 2011-2018 | 52 | 1 |
| Diabetes Care Devices Market, Australia, Revenue ($m), 2004-2011 | 53 | 1 |
| Diabetes Care Devices Market, Australia, Revenue ($m), 2011-2018 | 54 | 1 |
| Diabetes Care Devices Market, Japan, Revenue ($m), 2004-2011 | 55 | 1 |
| Diabetes Care Devices Market, Japan, Revenue ($m), 2011-2018 | 56 | 1 |
| Diabetes Care Devices Market, China, Revenue ($m), 2004-2011 | 57 | 1 |
| Diabetes Care Devices Market, China, Revenue ($m), 2011-2018 | 58 | 1 |
| Diabetes Care Devices Market, India, Revenue ($m), 2004-2011 | 59 | 1 |
| Diabetes Care Devices Market, India, Revenue ($m), 2011-2018 | 60 | 1 |
| Diabetes Care Devices Market, Brazil, Revenue ($m), 2004-2011 | 61 | 1 |
| Diabetes Care Devices Market, Brazil, Revenue ($m), 2011-2018 | 62 | 1 |
| Global Diabetes Care Devices Market - Competitive Assessment | 63 | 8 |
| F. Hoffmann-La Roche Ltd. | 63 | 1 |
| Business Overview | 64 | 1 |
| Key Marketed Products | 64 | 1 |
| LifeScan, Inc. | 64 | 1 |
| Business Overview | 64 | 1 |
| Key Marketed Products | 65 | 1 |
| Medtronic, Inc. | 65 | 1 |
| Business Overview | 65 | 1 |
| Key Marketed Products | 65 | 1 |
| Novo Nordisk A/S | 66 | 1 |
| Business Overview | 66 | 1 |
| Key Marketed Products | 66 | 1 |
| Sanofi | 67 | 1 |
| Business Overview | 67 | 1 |
| Key Marketed Products | 68 | 1 |
| Eli Lilly and Company | 68 | 1 |
| Business Overview | 68 | 1 |
| Key Marketed Products | 68 | 1 |
| Bayer HealthCare AG | 69 | 1 |
| Business Overview | 69 | 1 |
| Key Marketed Products | 69 | 1 |
| Abbott Laboratories | 69 | 1 |
| Business Overview | 69 | 1 |
| Key Marketed Products | 70 | 1 |
| Becton, Dickinson and Company | 70 | 1 |
| Business Overview | 70 | 1 |
| Key Marketed Products | 70 | 1 |
| Global Diabetes Care Devices Market - Pipeline Analysis | 71 | 22 |
| Glucose Monitoring Devices: Product Pipeline | 72 | 1 |
| Glucose Monitoring Devices: List of Pipeline Products | 72 | 4 |
| Glucose Monitoring Devices: Profiles of Key Pipeline Products | 76 | 1 |
| Enlite Sensor | 76 | 1 |
| C8 MediSensors Optical Glucose Monitor | 77 | 1 |
| GlucoTrack | 77 | 1 |
| Integrated Guardian Real-Time Continuous Glucose Monitoring System | 78 | 1 |
| NBM-200G | 78 | 1 |
| OptiScannner | 79 | 1 |
| Animas Vibe Insulin Pump and CGM System | 79 | 1 |
| Easy Check Breath Glucose Detection System | 80 | 1 |
| EyeSense Blood Glucose Measurement Device | 80 | 1 |
| Redscan | 81 | 1 |
| 5th Generation Short-term Sensor | 81 | 1 |
| Insulin Delivery Devices: Product Pipeline | 82 | 1 |
| Insulin Delivery Devices: List of Pipeline Products | 82 | 2 |
| Insulin Delivery Devices: Profiles of Key Pipeline Products | 84 | 1 |
| Paradigm Veo System | 84 | 1 |
| ClikSTAR | 84 | 1 |
| NovoPen Echo | 85 | 1 |
| Next Generation OneTouch Ping | 85 | 1 |
| Eros Insulin Pump | 86 | 1 |
| Needle-Free Injection Device | 86 | 1 |
| Spring Zone Insulin Delivery System | 87 | 1 |
| Solo MicroPump Insulin Delivery System | 87 | 1 |
| PaQ Insulin Delivery Device | 88 | 1 |
| Jewel Pump | 88 | 1 |
| Cellnovo Wireless Insulin Pump System | 89 | 1 |
| Artificial Pancreas: Product Pipeline | 90 | 1 |
| Artificial Pancreas: List of Pipeline Products | 90 | 1 |
| Artificial Pancreas: Profiles of Key Pipeline Products | 90 | 1 |
| Artificial Pancreas | 90 | 1 |
| Bionic Pancreas | 90 | 1 |
| Closed-Loop Artificial Pancreas System | 91 | 1 |
| MiniMed Closed Loop Insulin Delivery System | 91 | 1 |
| Other Diabetes Care Devices | 92 | 1 |
| Other Diabetes Care Devices: List of Pipeline Products | 92 | 1 |
| Global Diabetes Care Devices Market - Consolidation Landscape | 93 | 8 |
| Key Deals: 2010-2012 (Q1, Q2) | 93 | 1 |
| EKF Diagnostics Holdings Sells International Brand Licensing AG | 93 | 1 |
| Deal Rationale | 93 | 1 |
| ActiveCare s Acquisition of 4G Biometrics | 94 | 1 |
| Deal Rationale | 94 | 1 |
| D. Medical Industries Completes Sale of its 57.5% Stake in NextGen Biomed | 94 | 1 |
| Deal Rationale | 94 | 1 |
| Insulet s Acquisition of Neighborhood Diabetes | 94 | 1 |
| Deal Rationale | 94 | 1 |
| Roche Holding s Acquisition of Medingo from Elron Electronic Industries | 94 | 1 |
| Deal Rationale | 95 | 1 |
| Key Partnership Deals: 2007-2012 (Q1, Q2) | 95 | 1 |
| Insulet s Agreement with Ypsomed Holding | 96 | 1 |
| Haselmeier s Distribution Agreement with Biocon | 96 | 1 |
| Roche Diagnostics Distribution Agreement with DexCom | 96 | 1 |
| Cellnovo s Technology Integration Agreement with LifeScan | 96 | 1 |
| Bayer HealthCare Diabetes Care s Partnership with Medtronic | 96 | 1 |
| PositiveID s Agreement with HMD BioMedical | 97 | 1 |
| Powder Pharma s Agreement with Health-Chem Diagnostics | 97 | 1 |
| Insulet s Distribution Agreement with GlaxoSmithKline | 97 | 1 |
| Dance Pharma s Licensing Agreement with Aerogen | 97 | 1 |
| EyeSense s Agreement with Qiagen | 97 | 1 |
| AgaMatrix s Agreement with Sanofi-Aventis | 97 | 1 |
| JDRF s Agreement with Becton, Dickinson and Company | 98 | 1 |
| Insulet s Distribution Agreement with Ypsomed Holding | 98 | 1 |
| Luminous Medical s Agreement with a Supplier of Electrochemical Sensors | 98 | 1 |
| Arkray s Distribution Agreement with Nipro Corporation | 98 | 1 |
| Edwards Lifesciences Agreement with DexCom | 98 | 1 |
| Oxygen Biotherapeutics Agreement with Glucometrics | 99 | 1 |
| Smiths Medical s Agreement with Abbott Labs | 99 | 1 |
| Mankind Pharma s Agreement with Roche Diagnostics | 99 | 1 |
| DexCom s Joint Venture with Animas | 99 | 1 |
| Insulet Corporation s Partnership with DexCom | 99 | 1 |
| BioPharmetics Agreement with HMD Biomedical | 100 | 1 |
| Appendix | 101 | 7 |
| Definitions | 101 | 2 |
| Diabetes Care Devices | 101 | 1 |
| Glucose Monitoring Devices | 101 | 1 |
| Blood Glucose Meters | 101 | 1 |
| Blood Glucose Test Strips | 101 | 1 |
| Lancets | 101 | 1 |
| Insulin Delivery Devices | 101 | 1 |
| Insulin Pens | 101 | 1 |
| Insulin Pumps | 102 | 1 |
| Insulin Syringes | 102 | 1 |
| Traditional Insulin Pump Accessories | 102 | 1 |
| Acronyms | 102 | 2 |
| Sources | 104 | 1 |
| Research Methodology | 105 | 2 |
| Secondary Research | 105 | 1 |
| Primary Research | 105 | 1 |
| Models | 106 | 1 |
| Forecasts | 106 | 1 |
| Expert Panels | 106 | 1 |
| Contact Us | 106 | 1 |
| Disclaimer | 107 | 1 |
